Diagnosis and treatment strategies of respiratory viral infection in transplant recipients
10.12464/j.issn.1674-7445.2025028
- VernacularTitle:移植受者呼吸道病毒感染的诊疗策略
- Author:
Chunrong JU
1
;
Chuangli HAO
2
;
Wujun XUE
2
;
Jianxing HE
1
Author Information
1. The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Respiratory Health Research Institute, National Respiratory Medical Center, National Clinical Research Center of Respiratory Diseases, State Key Laboratory of Respiratory Diseases, Guangzhou 510120, China.
2. .
- Publication Type:Editorial
- Keywords:
Respiratory virus;
Solid organ transplantation;
Hematopoietic stem cell transplantation;
Antiviral therapy;
Influenza virus;
SARS-CoV-2;
Cytomegalovirus;
Respiratory syncytial virus
- From:
Organ Transplantation
2025;16(2):220-228
- CountryChina
- Language:Chinese
-
Abstract:
Viral infection has always been a significant challenge to human health. Transplant recipients, including those who have undergone solid organ transplantation and allogeneic hematopoietic stem cell transplantation, are at high risk of viral infection due to their weak immune function under immunosuppressive therapy. Unlike the general population, transplant recipients are prone to pneumonia and even severe pneumonia after respiratory viral infection, which requires close attention from clinicians. Therefore, this article reviews the clinical characteristics and special management of viral infection in this population, focusing on the epidemiological features of common respiratory viral infection in transplant recipients, early diagnosis and intervention after infection, severe warning signs and drug treatment strategies, for the reference of clinical colleagues.
